Senior Director TA Portfolio Delivery Lead
CSL
Senior Director TA Portfolio Delivery Lead
CSL
Develops and delivers biotherapies and vaccines
Location: King of Prussia, PA, USA or Maidenhead, UK
Work Arrangement: Hybrid – Onsite three days per week
Reports To: Vice President, Portfolio & Operations Excellence, CSL Behring
CSL Behring is a global biopharmaceutical leader committed to developing innovative therapies for patients with rare and serious diseases.
Our Immunoglobulins franchise is advancing a diverse pipeline targeting autoimmune and inflammatory conditions across rheumatology, neuroimmunology, and rare dermatology. Through scientific innovation and a commitment to patients, we strive to transform treatment options and address significant unmet medical needs.
Based on the assigned Therapeutic Area (TA), this global leadership role is responsible for the strategic and operational oversight of R&D Program Management, Development Planning, Project Management, and Therapeutic Area Portfolio & Operations. The role oversees functional project management across the respective therapeutic area, including development and regulatory programs, New Product Development, and Life Cycle Management.
Acting as a strategic partner to Therapeutic Area and R&D leadership, this individual drives effective portfolio planning, enables agile project delivery, and ensures alignment across cross-functional teams and geographies. As a key member of the Portfolio & Operations Excellence (POE) Leadership Team, the role proactively identifies and removes barriers to execution, addresses organizational and operational challenges, and drives accountability to ensure successful delivery of the R&D portfolio.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
CSL is a global biotechnology company that develops and delivers biotherapies and influenza vaccines. It focuses on plasma-derived and recombinant therapies for rare and serious diseases and sells to healthcare providers, hospitals, and governments across the Americas, Asia Pacific, and Europe. Its product range includes treatments for rare diseases, influenza vaccines, and antivenoms, produced through its R&D, manufacturing, and distribution operations. CSL differentiates itself by offering the broadest portfolio of plasma-derived and recombinant therapies and by leveraging its global footprint and emphasis on diversity to reach diverse markets. The company’s main goal is to save lives and protect health by expanding access to high-quality therapies and vaccines worldwide.
Explore more opportunities at CSL